CA Patent

CA2617688C — Solid dosage formulations containing weight-loss drugs

Assigned to Alpex Pharma SA · Expires 2015-08-18 · 11y expired

What this patent protects

An orally disintegrating tablet which can be chewed or disintegrated by contact with saliva and containing weight-loss drugs for weight control in humans, especially in children and adolescents, is disclosed.

USPTO Abstract

An orally disintegrating tablet which can be chewed or disintegrated by contact with saliva and containing weight-loss drugs for weight control in humans, especially in children and adolescents, is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
CA2617688C
Jurisdiction
CA
Classification
—
Expires
2015-08-18
Drug substance claim
No
Drug product claim
No
Assignee
Alpex Pharma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.